FDA Clears ExAblate Fertility Enhancement Study In Women With Uterine Fibroids

InSightec Ltd. announced that the U.S. Food and Drug Administration (FDA) cleared the company to conduct a clinical trial to evaluate the efficacy and safety of the ExAblate(R) 2000 system utilizing MR-guided Focused Ultrasound Surgery (MRgFUS) for the enhancement of fertility in women with non-hysteroscopically resectable uterine fibroids who are diagnosed with unexplained infertility. Twenty U.S.

More: continued here

Filed under: Fertility on June 1st, 2008